NAMI Advocacy Actions

NAMI works with policymakers to advance priority issues and ensure that the voice of people affected by mental illness is considered in policymaking. Read NAMI’s recent letters to federal leaders, submitted comments and testimony and other resources.

Filter By:
Letter to Congressional Committee Leadership on Medication Access
Letter to Senate Finance Committee Chairman Wyden and Ranking Member Crapo, urging the Committee to include the Non-Opioids Prevent Addiction in the Nation (“NOPAIN”) Act (S. 586) in the mental health legislative package currently under development.
Letter to Congressional Committee Leadership on Research & Treatment Innovation
Letter to Appropriations Committee leadership, requesting $3.75 billion for the Centers for Disease Control and Prevention’s National Center for Chronic Disease Prevention and Health Promotion.
Letter to Congressional Bill Sponsors on Mental Health Workforce
Letter to Senators Kaine and Young and Representatives Wild and McKinley, in thanks for championing H.R. 1667, the Dr. Lorna Breen Health Care Provider Protection Act, and ensuring its passage.
Statement on Health Coverage
Statement on consensus health care reform principles, including affordability, accessibility, adequacy and comprehensiveness.
Letter to CMS Administrator on Health Equity
Letter to Administrator Brooks-LaSure, requesting that CMS take action to address a the lack of timely operating room access for individuals with disabilities in need of dental surgical services.
Letter to Congressional Committee Leadership on Health Coverage
Letter to Healthy Future Task Force leadership, providing feedback on the Task Force's Request For Information on health care affordability.
Letter to Congressional Leadership on Parity
Letter to Speaker Pelosi and Leader Schumer, urging continued support for civil monetary penalty authority for the U.S. Department of Labor to enforce the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA).
Letter to CMS Administrator on Medicaid
Letter to CMS Administrator Brooks-LaSure, thanking the CMS for the agency’s recent decision to remove a financial barrier to Medicaid coverage by rejecting and phasing out premiums in Section 1115 waivers.
Letter to FDA on Medication Access
Letter to the FDA regarding reporting and treatment recommendation updates to the Clozapine Risk Evaluation and Mitigation Strategies (REMS) surveillance system.
Letter to Congressional Leadership on Health Coverage
Letter to Speaker Pelosi and Leader Schumer, urging Congress to permanently expand ACA programs including the enhanced advance premium tax credits (APTCs) and close the Medicaid coverage gap in the Fiscal Year 2022 budget reconciliation process.
Displaying results 31-40 (of 181)
 <  1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >